HOP-STEP Program for Lupus
(HOP-STEPsIRB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to adapt and test the HOP-STEP program at a new location to help women with lupus plan their pregnancies and use contraception more effectively. The program educates healthcare providers and restructures clinics to offer better support, especially in high-minority, high-poverty areas.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
How is the HOP-STEP treatment for lupus different from other treatments?
The HOP-STEP treatment is unique because it focuses on educating healthcare providers to improve pregnancy outcomes for women with lupus, rather than directly treating the disease itself. This approach emphasizes pre-pregnancy counseling and a multidisciplinary care pathway to manage the complex risks associated with lupus during pregnancy.12345
What data supports the effectiveness of the HOP-STEP treatment for lupus?
Who Is on the Research Team?
Megan E Clowse, MD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for clinical rheumatology providers at the University of Chicago Medical Center. It aims to improve maternal health in women with lupus by educating providers on pregnancy planning and contraception.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Period
Implementation and evaluation of the HOP-STEP intervention in a high-minority, high-poverty academic rheumatology center
Follow-up
Participants are monitored for the effectiveness and adoption of the HOP-STEP intervention
What Are the Treatments Tested in This Trial?
Interventions
- HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Intervention
- Routine Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator
University of Chicago
Collaborator
National Institutes of Health (NIH)
Collaborator